EBOS Group Valuation
| EBOSY Stock | USD 35.03 0.00 0.00% |
At this time, the entity appears to be undervalued. EBOS Group Limited shows a prevailing Real Value of $36.76 per share. The current price of the entity is $35.03. Our model computes the value of EBOS Group Limited from analyzing the entity fundamentals such as Profit Margin of 0.02 %, operating margin of 0.03 %, and Current Valuation of 5.9 B as well as examining its technical indicators and probability of bankruptcy.
Undervalued
Today
Please note that EBOS Group's price fluctuation is very steady at this time. Calculation of the real value of EBOS Group Limited is based on 3 months time horizon. Increasing EBOS Group's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since EBOS Group is currently traded on the exchange, buyers and sellers on that exchange determine the market value of EBOS Pink Sheet. However, EBOS Group's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 35.03 | Real 36.76 | Hype 35.03 | Naive 34.94 |
The intrinsic value of EBOS Group's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence EBOS Group's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of EBOS Group Limited helps investors to forecast how EBOS pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of EBOS Group more accurately as focusing exclusively on EBOS Group's fundamentals will not take into account other important factors: EBOS Group Total Value Analysis
EBOS Group Limited is currently projected to have takeover price of 5.9 B with market capitalization of 2.98 B, debt of 1.16 B, and cash on hands of 103.76 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the EBOS Group fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
5.9 B | 2.98 B | 1.16 B | 103.76 M |
EBOS Group Investor Information
The book value of the company was currently reported as 22.62. The company last dividend was issued on the 26th of September 2018. Based on the analysis of EBOS Group's profitability, liquidity, and operating efficiency, EBOS Group Limited is not in a good financial situation at this time. It has a very high probability of going through financial hardship in January.EBOS Group Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. EBOS Group has an asset utilization ratio of 171.35 percent. This suggests that the Company is making $1.71 for each dollar of assets. An increasing asset utilization means that EBOS Group Limited is more efficient with each dollar of assets it utilizes for everyday operations.EBOS Group Profitability Analysis
The company reported the revenue of 11.9 B. Net Income was 224.64 M with profit before overhead, payroll, taxes, and interest of 984.31 M.About EBOS Group Valuation
Our relative valuation model uses a comparative analysis of EBOS Group. We calculate exposure to EBOS Group's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of EBOS Group's related companies.EBOS Group Limited engages in the marketing, wholesale, and distribution of healthcare, medical, pharmaceutical, and animal care products in Australia and New Zealand. EBOS Group Limited was founded in 1922 and is headquartered in Docklands, Australia. Ebos Group is traded on BATS Exchange in USA.
8 Steps to conduct EBOS Group's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates EBOS Group's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct EBOS Group's valuation analysis, follow these 8 steps:- Gather financial information: Obtain EBOS Group's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine EBOS Group's revenue streams: Identify EBOS Group's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research EBOS Group's industry and market trends, including the size of the market, growth rate, and competition.
- Establish EBOS Group's growth potential: Evaluate EBOS Group's management, business model, and growth potential.
- Determine EBOS Group's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate EBOS Group's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
EBOS Group Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 189.4 M | |
| Quarterly Earnings Growth Y O Y | 0.08 | |
| Forward Price Earnings | 22.9885 | |
| Retained Earnings | 534.1 M |
Additional Tools for EBOS Pink Sheet Analysis
When running EBOS Group's price analysis, check to measure EBOS Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy EBOS Group is operating at the current time. Most of EBOS Group's value examination focuses on studying past and present price action to predict the probability of EBOS Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move EBOS Group's price. Additionally, you may evaluate how the addition of EBOS Group to your portfolios can decrease your overall portfolio volatility.